Catheter Precision, Inc. current report, 03 May 2020

SEC Filing Summary: Ra Medical Systems, Inc. (RMED)

Business Context and Reporting Period

This Form 8-K was filed on May 6, 2020, reporting events occurring on May 3, 2020. The registrant is Ra Medical Systems, Inc., a Delaware corporation trading on the New York Stock Exchange under the symbol RMED. The filing discloses the entry into a material definitive agreement regarding a government-backed loan.

Key Financial Metrics

The filing details a new debt instrument but does not provide comprehensive financial statements, revenue, profit, or cash flow data for the period.

  • New Debt Principal: $2.0 million
  • Interest Rate: 1.0% per annum
  • Term: 2 years (maturing May 3, 2022)
  • Collateral: None provided
  • Facility Charge: None paid

Material Changes

The primary material change is the creation of a direct financial obligation under the Small Business Administration's (SBA) Paycheck Protection Program (PPP). This represents a new liability on the balance sheet, subject to potential forgiveness.

Outlook, Risks, and Unusual Items

Loan Forgiveness Conditions: The loan may be partially or fully forgiven if the Company complies with the CARES Act. Full forgiveness requires using 75% of proceeds for covered payroll costs and no more than 25% for approved non-payroll costs over an eight-week period from disbursement.

Repayment Terms: Principal and interest are payable in monthly installments beginning November 1, 2020, for any portion not forgiven. The Company may prepay without penalty.

Risks: The agreement includes customary events of default, including failure to make payment, bankruptcy, breaches of representations, and material adverse effects.

Investor Verification Checklist

  • Verify the actual disbursement date of the $2.0 million loan to confirm the start of the eight-week forgiveness period.
  • Monitor future filings to confirm the allocation of funds between payroll (target 75%) and non-payroll expenses.
  • Review subsequent 10-Q or 10-K filings to determine if the loan was forgiven or if repayment obligations were triggered.
  • Confirm the Company's liquidity position post-loan, as this filing does not disclose total cash balances.